AI Tumor Detection Failures: $400M Cost & New Rules
This story is from 2026-10-24. It is preserved in the archive; the latest stories are on the live feed.
Computer vision for early tumor detection works in at least one large randomized trial (Sweden’s MASAI, 2026). Regulators now require more lifecycle control, but most cleared devices still reach the market without a prospective clinical study. Only tumor and cancer detection cases are treated as ca…
Read the full story at DEV Community — AI ↗
Timeline · 1 report
- 2026-10-24 09:29 · DEV Community — AI
AI Tumor Detection Failures: $400M Cost & New Rules